Tuesday, October 24, 2023
Elon Musk aims to conquer a new frontier.
No, I don’t mean outer space, the focus of his SpaceX venture. And I’m not referring to social media, where he made a giant splash last year in acquiring Twitter (now known as “X”).
Interestingly, the frontier I’m talking about isn’t very big. In fact, it’s the space right between your ears.
It’s an area that Musk aims to conquer with what could become his most valuable enterprise...
And today, I’ll reveal how we can position ourselves to profit from its success.
Perhaps you’ve heard of Musk’s urge to get inside your head. And I do mean that literally.
You see, seven years ago, Musk founded Neuralink, a neurotechnology company with a focus on neuroscience, biochemistry, and robotics.
Of course, with Musk, it’s always about the “big idea” — like landing a man on Mars (SpaceX), building a self-driving car (Tesla), or creating a network of underground tunnels (The Boring Company). And that was certainly true with Neuralink.
You see, Neuralink is developing implantable brain-computer interfaces (“BCIs”), tiny devices that act as direct communication links between the brain’s electrical activity and an external device — a computer or robotic limb, for example.
Here’s a picture of what the device might look like:
Essentially, a tiny coin-sized chip called the Link (shown on the right) will be inserted under the skull. From this chip, dozens of hair-thin wires will be extended into the brain.
These wires will both read brain activity and send signals. And each one is so thin and flexible, no human could possibly insert them...
Which is why Neuralink has also developed a fully-autonomous surgical robot that will handle installation. A battery outside the skull will be used to power the chip.
If it seems like something from a science-fiction novel, you’re on the right track. Musk got the idea for these implants partly from a popular sci-fi book series called “The Culture.”
But these implants could really happen...
And their potential impact could be life-changing.
Consider, for example, those suffering from Parkinson’s Disease, a group Neuralink aims to initially target.
Parkinson’s is a brain disorder that causes unintended or uncontrollable movements. Over time, people may lose the ability to move or talk altogether.
BCIs like Neuralink’s could correct signals sent from the brain to the body, bridging any gaps caused by the disease and removing noise from the signal.
Globally, an estimated 1.2 billion people either are, or will be, afflicted with Parkinson’s. The global market for treating and addressing this disease is projected to surpass $17 billion in ten years.
Of course, not every Parkinson’s sufferer will qualify for a Neuralink implant. But this device could help other types of patients...
For example, paralysis could be cured by having the implant bridge the gap between the brain and body. And those battling depression, schizophrenia, and other conditions could benefit from the implant correcting abnormal brain signaling.
But before these implants can get anywhere near the open market, they must first undergo extensive testing. That includes clinical trials involving human volunteers.
You see, Musk is seeking volunteers for an upcoming clinical trial. Neuralink received approval for this trial from the Food and Drug Administration (“FDA”) back in May, but no details were revealed at the time.
Today, we know the company will implant BCIs into patients who have suffered paralysis below the neck and monitor them for six years.
Initially, Neuralink will aim to enable patients to type on a computer using only their thoughts. And the mind-control possibilities extend from there.
The potential of this technology is why Neuralink is already a valuable enterprise. On the heels of clinical-trial approval, the company raised $280 million in a round led by tech billionaire Peter Thiel’s Founders Fund. Even before this round, Neuralink was valued at $5 billion.
Investors like Thiel could wind up with a windfall of profits one day. And I’d love for us to join him.
Unfortunately, Neuralink isn’t raising any funds from individual investors like us — at least, not right now. No matter, though...
I’ve got a way we can invest in the technology behind this company’s implants and still position ourselves for profits. Let me explain...
You see, there’s an important technology that Neuralink’s BCIs can’t work without. I’m talking about microcontrollers — tiny, all-in-one computers housed on a single chip.
These controllers read their environments for changes in movement, temperature, and pressure. And they wait for signals sent via sound, light, or Wi-Fi to control small motors and radios.
Microcontrollers are everywhere — from water pumps to television clickers to children’s toys. They’re also in medical devices, fighter jets, satellites, missiles, and almost anything else you can think of.
In Neuralink’s implant, all the signal processing that enables the device to read what the brain is doing and respond is thanks to microcontrollers.
With that in mind, let’s focus on a company that’s a leader in the microcontroller sector. I’ve saved the details for “Pro” readers, so don’t miss out.
FOR TREND TRADER PRO READERS ONLY
>>>>>>>>>> Learn more <<<<<<<<<<
Cheers and Good Investing,
Chief Investment Officer
Trend Trader Daily